Results of a phase I study of bendamustine in combination with ofatumumab, carboplatin, and etoposide (BOCE) for refractory or relapsed aggressive B-cell non-Hodgkin lymphomas (NHL)
Gaballa, Sameh, Palmisiano, Neil David, Asija, Aakanksha, Chapman, Andrew E., Cloud, Jennifer K., Filicko-O'Hara, Joanne E., Rose, Lewis J., Ramirez, Michael J., Alpdogan, Onder, Flomenberg, Neal, Pro, Barbara, Gitelson, Elena, Weiss, Mark Adam
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article